PE/DazzleTM 594 anti-human CD194 (CCR4) [L291H4] and 26 more items

BioLegend Inc. has been awarded a purchase order (A207_PO-0445037) by the University of Virginia, valued at $7,025.00, effective June 3, 2026. The contract encompasses the procurement of 27 line items consisting of fluorescently-labeled monoclonal antibodies for flow cytometry applications. These antibodies target various human immune cell surface markers and intracellular antigens, including but not limited to CD3, CD8a, CD14, CD19, CD25, CD28, CD38, CD45RA, CD56, CD95, CD194 (CCR4), CD197 (CCR7), CD279 (programmed death-1), and T-bet. The antibodies are conjugated to diverse fluorescent dyes and detection systems including phycoerythrin (PE), fluorescein isothiocyanate (FITC), Brilliant Violet variants, Alexa Fluor 488, and proprietary BioLegend technologies such as Spark and Dazzle dyes.

All deliveries under this contract are directed to Glenda Canderan at the University of Virginia in Virginia. The purchase order represents a single transaction for research-grade immunological reagents, with quantities per line item ranging from one to two units and unit prices ranging from $72.10 to $334.50. These materials are consistent with applications in immunological research, flow cytometry panel development, and translational medical research conducted at the university.